144 related articles for article (PubMed ID: 15888163)
1. Study of a myo-inositol hexaphosphate-based cream to prevent dystrophic calcinosis cutis.
Grases F; Perelló J; Isern B; Prieto RM
Br J Dermatol; 2005 May; 152(5):1022-5. PubMed ID: 15888163
[TBL] [Abstract][Full Text] [Related]
2. Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats.
Grases F; Perelló J; Prieto RM; Simonet BM; Torres JJ
Life Sci; 2004 May; 75(1):11-9. PubMed ID: 15102518
[TBL] [Abstract][Full Text] [Related]
3. Study of the absorption of myo-inositol hexakisphosphate (InsP6) through the skin.
Grases F; Perelló J; Isern B; Prieto RM
Biol Pharm Bull; 2005 Apr; 28(4):764-7. PubMed ID: 15802828
[TBL] [Abstract][Full Text] [Related]
4. Role of phytate and osteopontin in the mechanism of soft tissue calcification.
Grases F; Prieto RM; Sanchis P; Saus C; De Francisco T
J Nephrol; 2008; 21(5):768-75. PubMed ID: 18949733
[TBL] [Abstract][Full Text] [Related]
5. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment.
Grases F; Costa-Bauzá A
Anticancer Res; 1999; 19(5A):3717-22. PubMed ID: 10625946
[TBL] [Abstract][Full Text] [Related]
6. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats.
Grases F; Sanchis P; Perello J; Isern B; Prieto RM; Fernandez-Palomeque C; Fiol M; Bonnin O; Torres JJ
Front Biosci; 2006 Jan; 11():136-42. PubMed ID: 16146720
[TBL] [Abstract][Full Text] [Related]
7. Study of potassium phytate effects on decreasing urinary calcium in rats.
Grases F; Perelló J; Simonet BM; Prieto RM; García-Raja A
Urol Int; 2004; 72(3):237-43. PubMed ID: 15084770
[TBL] [Abstract][Full Text] [Related]
8. Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.
Grases F; Costa-Bauza A
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817119
[TBL] [Abstract][Full Text] [Related]
9. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption.
Grases F; Isern B; Perelló J; Sanchis P; Prieto RM
Front Biosci; 2005 Jan; 10():799-802. PubMed ID: 15569619
[TBL] [Abstract][Full Text] [Related]
10. Dietary inositol hexakisphosphate, but not myo-inositol, clearly improves hypercholesterolemia in rats fed casein-type amino acid mixtures and 1,1,1-trichloro-2,2-bis (p-chlorophenyl) ethane.
Okazaki Y; Katayama T
Nutr Res; 2008 Oct; 28(10):714-21. PubMed ID: 19083479
[TBL] [Abstract][Full Text] [Related]
11. Phytate reduces age-related cardiovascular calcification.
Grases F; Sanchis P; Perello J; Isern B; Prieto RM; Fernandez-Palomeque C; Saus C
Front Biosci; 2008 May; 13():7115-22. PubMed ID: 18508720
[TBL] [Abstract][Full Text] [Related]
12. Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats.
Grases F; Sanchis P; Perelló J; Isern B; Prieto RM; Fernández-Palomeque C; Torres JJ
Circ J; 2007 Jul; 71(7):1152-6. PubMed ID: 17587727
[TBL] [Abstract][Full Text] [Related]
13. A novel treatment for ulcerative calcinosis cutis.
Bair B; Fivenson D
J Drugs Dermatol; 2011 Sep; 10(9):1042-4. PubMed ID: 22052275
[TBL] [Abstract][Full Text] [Related]
14. Phytate acts as an inhibitor in formation of renal calculi.
Grases F; Isern B; Sanchis P; Perello J; Torres JJ; Costa-Bauza A
Front Biosci; 2007 Jan; 12():2580-7. PubMed ID: 17127264
[TBL] [Abstract][Full Text] [Related]
15. Phytate prevents tissue calcifications in female rats.
Grases F; Prieto RM; Simonet BM; March JG
Biofactors; 2000; 11(3):171-7. PubMed ID: 10875304
[TBL] [Abstract][Full Text] [Related]
16. Calcinosis of the cutis and subcutis: an unusual nonimmunologic adverse reaction to subcutaneous injections of low-molecular-weight calcium-containing heparins.
Eich D; Scharffetter-Kochanek K; Weihrauch J; Krieg T; Hunzelmann N
J Am Acad Dermatol; 2004 Feb; 50(2):210-4. PubMed ID: 14726874
[TBL] [Abstract][Full Text] [Related]
17. Calcinosis cutis following the administration of intravenous calcium therapy.
Kagen MH; Bansal MG; Grossman M
Cutis; 2000 Apr; 65(4):193-4. PubMed ID: 10795076
[TBL] [Abstract][Full Text] [Related]
18. Myo-inositol hexakisphosphate degradation by Bifidobacterium infantis ATCC 15697.
Haros M; Bielecka M; Honke J; Sanz Y
Int J Food Microbiol; 2007 Jun; 117(1):76-84. PubMed ID: 17462768
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous calcinosis induced by topical calciphylaxis in rats. I. Ultrastructural aspcts].
Boivin G
Arch Anat Microsc Morphol Exp; 1975; 64(2):183-205. PubMed ID: 1217906
[TBL] [Abstract][Full Text] [Related]
20. Calcinosis cutis following contact with calcium chloride solution.
Lim PP; Kossard S; Stapleton K
Australas J Dermatol; 2012 Nov; 53(4):e66-8. PubMed ID: 23157788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
